Gene · 23642
SNHG1: small nucleolar RNA host gene 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SNHG1: small nucleolar RNA host gene 1. Genes, record 23642. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23642
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants211
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SNHG1 papers | Newest fiscal year |
|---|---|---|---|
| P50CA127001 | SPORE in Brain Cancer | 2 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 2 | 2025 |
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 2 | 2025 |
| I01BX004837 | Role of nitro-fatty acids in BBB stabilization and post-stroke neurovascular protection | 1 | 2025 |
| IK6BX004601 | BLR&D Research Career Scientist Award | 1 | 2025 |
| K08HL157619 | Long noncoding RNA-mediated regulation of T-cell alloimmunity | 1 | 2025 |
| P01CA013106 | Targeting Transcription and Splicing in Cancer | 1 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 1 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 1 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 1 | 2025 |
1 to 10 of 211Source NIH's project files
See all 211 nih grantsPapers1,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cellular and microenvironmental functions of SNHG lncRNAs in tumor immune remodeling. | Tissue Cell | 2026 | 42777519 | PubTator, text mining | PubMed |
| MYC-regulated long non-coding RNA SNHG1 controls S-phase kinase-associated protein 2-mediated p21 protein stability under thyroid hormone receptor signaling in hepatocellular carcinoma. | Int J Biol Macromol | 2026 | 42735764 | PubTator, text mining | PubMed |
| Retraction notice to "Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497" [Biochem. Biophys. Res. Commun. 506 (2018) 632-640]. | Biochem Biophys Res Commun | 2026 | 42716843 | PubTator, text mining | PubMed |
| SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications. | NAR Cancer | 2026 | 42656604 | PubTator, text mining | PubMed |
| SnoRNA and SNHG in Bladder Cancer: Molecular Mechanisms and Clinical Significance. | Curr Issues Mol Biol | 2026 | 42510903 | PubTator, text mining | PubMed |
| Integrative Bioinformatic Characterization of the HDAC6-Driven Cytoskeleton-Wnt Signaling Interface in Hepatocellular Carcinoma: Implications for Immune Modulation and Therapeutic Targeting. | Int J Mol Sci | 2026 | 42352927 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients. | Int J Cancer | 2026 | 42338005 | PubTator, text mining | PubMed |
| Cross-Level Regulatory Interactions Underlying Human Immune Aging. | MedComm (2020) | 2026 | 42311858 | PubTator, text mining | PubMed |
| Regulation of SNHG1, SNHG3, SNHG4 and SNHG5 in peripheral blood mononuclear cells in rheumatoid arthritis. | Sci Rep | 2026 | 42209629 | PubTator, text mining | PubMed |
1 to 10 of 1,503
See all 1,503 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/23642
GET https://conductscience.org/api/genes/v1/23642/grants?page=2